Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5799
-1.71 %
$ 148 M
Market Cap
-3.41
P/E
ADAP - COST OF REVENUE
Cost of Revenue ADAP - Adaptimmune Therapeutics plc
9.86 M
LAST VALUE
-70.21%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR